HUMAN PAPILLOMAVIRUS (HPV) TYPES SPECIFIC OF EPIDERMODYSPLASIA-VERRUCIFORMIS DETECTED IN WARTS INDUCED BY HPV3 OR HPV3-RELATED TYPES IN IMMUNOSUPPRESSED PATIENTS

被引:51
作者
OBALEK, S
FAVRE, M
SZYMANCZYK, J
MISIEWICZ, J
JABLONSKA, S
ORTH, G
机构
[1] INST PASTEUR,INSERM,UNITE PAPILLOMAVIRUS 190,25 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE
[2] WARSAW ACAD MED & HOSP,DEPT DERMATOL,WARSAW,POLAND
关键词
D O I
10.1111/1523-1747.ep12460892
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Epidermodysplasia verruciformis (EV) is characterized by an abnormal genetic predisposition to infection with specific types of human papillomavirus (HPV). Specific defects of the cell-mediated immunity and/or of the control of HPV infection in keratinocytes are assumed to be involved in the development of the disease. As a model to test this hypothesis, we have studied the prevalence of EV-specific HPV in skin warts of 56 immunosuppressed patients. All main types of cutaneous HPV (HPV1, 2, 3, 4, 10, and 28) responsible for skin warts in the general population were detected by blot hybridization. EV-specific HPV (HPV5, 20, and 23) were detected in three patients. Four additional patients were found infected with HPV49, first characterized in the course of this study, and found to be related to EV HPV. A most important finding was that HPV5, 20, 23, and 49 were always codetected with HPV3 or the related types HPV10 and 28. None of the specimens showed the typical clinical morphology of EV lesions. In none of these specimens was the specific cytopathic effect of EV recognized; instead that of HPV3 and related types was seen. No evidence for productive EV HPV DNA replication was obtained for the three specimens that could be further analyzed by in situ hybridization. Our data suggest that HPV3 infection favors infection with EV HPV in immunosuppressed patients but that the full expression of EV HPV is usually restricted as in the general population.
引用
收藏
页码:936 / 941
页数:6
相关论文
共 37 条
[11]  
FUCHS PG, 1990, PAPILLOMAVIRUS REP, V1, P1
[12]   PAPILLOMAVIRUS DNA IN WARTS OF IMMUNOSUPPRESSED RENAL-ALLOGRAFT RECIPIENTS [J].
GASSENMAIER, A ;
FUCHS, P ;
SCHELL, H ;
PFISTER, H .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1986, 278 (03) :219-223
[13]  
Goldes J A, 1984, Pediatr Dermatol, V2, P136, DOI 10.1111/j.1525-1470.1984.tb00458.x
[14]   CHARACTERIZATION OF A NEW HUMAN PAPILLOMAVIRUS (HPV 41) FROM DISSEMINATED WARTS AND DETECTION OF ITS DNA IN SOME SKIN CARCINOMAS [J].
GRIMMEL, M ;
DEVILLIERS, EM ;
NEUMANN, C ;
PAWLITA, M ;
HAUSEN, HZ .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) :5-9
[15]   EPIDERMODYSPLASIA-VERRUCIFORMIS IN A PATIENT WITH HODGKINS-DISEASE - CHARACTERIZATION OF A NEW PAPILLOMAVIRUS TYPE AND INTERFERON TREATMENT [J].
GROSS, G ;
ELLINGER, K ;
ROUSSAKI, A ;
FUCHS, PG ;
PETER, HH ;
PFISTER, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (01) :43-48
[16]  
Jablonska S, 1985, Clin Dermatol, V3, P71, DOI 10.1016/0738-081X(85)90051-3
[17]   EPIDERMODYSPLASIA VERRUCIFORMIS VERSUS DISSEMINATED VERRUCAE PLANAE - IS EPIDERMODYSPLASIA VERRUCIFORMIS A GENERALIZED INFECTION WITH WART VIRUS [J].
JABLONSKA, S ;
ORTH, G ;
JARZABEKCHORZELSKA, M ;
RZESA, G ;
OBALEK, S ;
GLINSKI, W ;
FAVRE, M ;
CROISSANT, O .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1979, 72 (03) :114-119
[18]  
JABLONSKA S, 1982, SPRINGER SEMIN IMMUN, V5, P33
[19]  
Jablonska S, 1985, Clin Dermatol, V3, P83, DOI 10.1016/0738-081X(85)90052-5
[20]   TYPES OF HUMAN PAPILLOMAVIRUS ISOLATED FROM JAPANESE PATIENTS WITH EPIDERMODYSPLASIA VERRUCIFORMIS [J].
KANDA, R ;
TANIGAKI, T ;
KITANO, Y ;
YOSHIKAWA, K ;
YUTSUDO, M ;
HAKURA, A .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (04) :463-469